These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24961937)

  • 21. Cirrhotic Endothelial Progenitor Cells Enhance Liver Angiogenesis and Fibrosis and Aggravate Portal Hypertension in Bile Duct-Ligated Cirrhotic Rats.
    Tripathi DM; Hassan M; Siddiqui H; Kaur I; Rawal P; Bihari C; Kaur S; Sarin SK
    Front Physiol; 2020; 11():617. PubMed ID: 32595520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
    Tung HC; Lee FY; Wang SS; Tsai MH; Lee JY; Huo TI; Huang HC; Chuang CL; Lin HC; Lee SD
    PLoS One; 2015; 10(5):e0124654. PubMed ID: 25933224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
    Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
    J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose alcohol exacerbates hyperdynamic circulation and shunting in non-alcoholic cirrhotic rats.
    Pun CK; Huang HC; Chang CC; Hsu SJ; Chuang CL; Huang YH; Hou MC; Lee FY
    Biosci Rep; 2024 Jul; 44(7):. PubMed ID: 38967060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
    Yang YY; Liu RS; Lee PC; Yeh YC; Huang YT; Lee WP; Lee KC; Hsieh YC; Lee FY; Tan TW; Lin HC
    Liver Int; 2014 Apr; 34(4):521-34. PubMed ID: 23998651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents.
    Huang HC; Ho HL; Chang CC; Chuang CL; Pun CK; Lee FY; Huang YH; Hou MC; Hsu SJ
    J Cell Mol Med; 2021 Nov; 25(21):10073-10087. PubMed ID: 34647412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
    Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
    Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptome analysis of mesenteric arterioles changes and its mechanisms in cirrhotic rats with portal hypertension.
    Wu G; Chen M; Fan Q; Li H; Zhao Z; Zhang C; Luo M
    BMC Genomics; 2023 Jan; 24(1):20. PubMed ID: 36641445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
    Lin HC; Yang YY; Tsai TH; Huang CM; Huang YT; Lee FY; Liu TT; Lee SD
    J Hepatol; 2011 Jun; 54(6):1145-53. PubMed ID: 21145843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
    Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
    J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic alterations in cirrhosis and portal hypertension.
    Kim MY; Baik SK; Lee SS
    Korean J Hepatol; 2010 Dec; 16(4):347-52. PubMed ID: 21415576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
    Wang X; Li J; Nong J; Deng X; Chen Y; Wu P; Huang X
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38438779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats.
    Yang YY; Lee TY; Huang YT; Chan CC; Yeh YC; Lee FY; Lee SD; Lin HC
    Liver Int; 2012 Jan; 32(1):48-57. PubMed ID: 22098317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat.
    Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD
    J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis.
    Hsin IF; Lee JY; Huo TI; Lee FY; Huang HC; Hsu SJ; Wang SS; Ho HL; Lin HC; Lee SD
    J Gastroenterol Hepatol; 2016 May; 31(5):1045-51. PubMed ID: 26474184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.